Pillar Resource: 7-OH Foundation
The Science of 7-Hydroxymitragynine
Discover the most potent alkaloid in the botanical world. Experience faster onset, targeted support, and unmatched isolation standards
Download Lab Reports
What is 7-Hydroxymitragynine?
7-Hydroxymitragynine (7-OH) is a terpenoid indole alkaloid found in trace amounts within the leaves of the Mitragyna speciosa tree. While the tree contains over 40 distinct alkaloids, 7-OH is unique due to its profound binding affinity, making it the most potent and effective component of the botanical profile.
Access 7-OH for Your Research
Our 7-OH Foundation isolates are the industry standard for purity, stability, and consistency.
In its natural state, 7-OH exists in nearly imperceptible quantities. To check its full potential for wellness support, sophisticated laboratory processes are used to isolate and concentrate the molecule into the high-purity format found at GetWell Depot.
Key Statistics
- CAS Number: 174418-82-7
- Purity Standard: 98%+ Isolation
- Receptor Type: Partial Agonist
Researcher Summary
“7-OH represents the bridge between traditional botanical use and advanced pharmaceutical-grade alkaloid research.”
The Oxidation Process of 7-OH
The “Foundation” of our 7-OH products begins with premium Mitragynine (MIT). Through a controlled, semi-synthetic oxidative synthesis, we simulate the natural metabolic pathways of the plant but at a much higher efficiency.
The Conversion Pathway: MIT → 7-OH
In nature, Mitragynine is converted into 7-OH through exposure to sunlight and oxygen. In a laboratory environment, we use highly specific catalysts to facilitate this oxidation. This process is crucial because 7-OH is often considered an “active metabolite”—meaning the body would naturally convert MIT to 7-OH in the liver via the CYP3A4 enzyme. By providing a 7-OH isolate, we allow for faster bioavailability and more consistent data by bypassing the metabolic bottleneck.
Pharmacology 7 Receptor Binding
The most groundbreaking aspect of 7-OH is its **G-protein biased signaling**. Traditional full-agonists recruit a protein called **Beta-Arrestin-2**, which is scientifically linked to side effects like respiratory depression and severe constipation.
- The "Ceiling Effect"
As a **partial agonist**, 7-OH possesses a pharmacological “ceiling.” This means that after a certain dosage point, the activation of receptors does not continue to increase linearly. This provides a significantly wider safety margin compared to synthetic full-agonists, making it a focal point for modern pain management research.
| Comparative Metric | Standard Kratom | 7-OH Isolate |
|---|---|---|
|
Binding Affinity (Ki) |
Low/Moderate |
High (≈ 2.5 nM) |
|
Metabolic Requirement |
Required (Liver Conversion) |
None (Bypass Path) |
|
Alkaloid Purity |
1-2% MIT |
98%+ Isolated 7-OH |
Dosage Guide & Responsible Use
Because 7-OH is significantly more potent than traditional kratom leaf, dosage must be approached with extreme caution.
Threshold
5-10mg
Ideal for initial assessment and sensitivity testing.
Standard
15mg
One standard tablet. The most common choice for relief and focus.
Advanced
20mg+
Experience dependent. Increased affinity requires careful management
7-OH Deep-Dive Resources
Essential reading for a complete understanding of the 7-OH.
MIT → 7-OH Guide
Understanding metabolic conversion and isolate pretictability.
Bioavailability Study
Sublingual vs. Oral administration comparative study.
Legality Hub
Real-time tracking of 7-OH and KCPA state regulations.
7-OH Research FAQ
Is 7-OH legal?
As of 2026, 7-OH is legal in most U.S. states where Kratom is permitted. However, certain states have age restrictions (21+) and specific labeling requirements under the Kratom Consumer Protection Act (KCPA).
Does 7-OH show up on a drug test?
Standard drug tests do not screen for 7-OH. However, specialized Kratom screenings are becoming more common in certain professional sectors.